secwatch.observer — SEC 8-K summary
======================================

Issuer:     P3 Health Partners Inc. (PIII)
CIK:        0001832511
Form:       8-K
Filed at:   2024-03-28T23:59:59+00:00
Accession:  0001628280-24-013613
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.02, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

P3 Health reports FY23 revenue $1.27B (+21% YoY); affirms 2024 Adj. EBITDA guidance $20M-$40M
--------------------------------------------------------------------------------

- Total revenue $1.27B for FY2023 (+21% YoY); net loss $186.4M vs $1.56B prior year.
- Medical margin $135.1M (+118% YoY); Adjusted EBITDA loss $85.5M (improved from $127.9M).
- Affirms 2024 guidance: at-risk members 125k-135k, revenue $1.45B-$1.55B, Adj. EBITDA $20M-$40M.
- P3 LLC entered $25M unsecured promissory note (17.5% interest) from VBC Growth SPV 2 for growth pipeline.
- Note subordinated to existing term loan; related-party transaction approved by independent committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832511/000162828024013613/0001628280-24-013613-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832511/000162828024013613/piii-20240322.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-013613

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer